Tag: Ovid Therapeutics Inc.
Ovid Therapeutics and Angelini Pharma Enter into Exclusive License Agreement to...
Angelini Pharma obtains exclusive development, manufacturing and commercialization rights to OV101 (gaboxadol) for the potential treatment of Angelman syndrome in the European Union...
- Advertisement -